Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition
Catherine Labinjoh, BSc, MB, ChB (Hons), MRCP*,
David E. Newby, BA, BSc, PhD, DM, (Hons), BM, MRCP*,* ,
M. Paola Pellegrini, MB, ChB*,
Neil R. Johnston, MSc*,
Nicholas A. Boon, BA, MB, MA, MD, BChir, FRCP and
David J. Webb, MB, MD, DSc, FRCP, FFPM, FMedSci*
* Clinical Pharmacology Unit and Research Centre, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, United Kingdom
Department of Cardiology, Royal Infirmary, Lauriston Place, Edinburgh, United Kingdom

View larger version (11K):
[in a new window]
|
Figure 1 Infused forearm blood flow response to intrabrachial infusion of substance P, sodium nitroprusside and bradykinin during placebo (open circles), quinapril (closed circles) and losartan (closed squares) administration. p < 0.001 (analysis of variance) for all blood flow responses.
|
|
|